The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Luminal and basal subtyping of metastatic castration-resistant prostate cancer (mCRPC) and its clinical implications.
 
Won Kim
Consulting or Advisory Role - Bayer; Dendreon; Genentech/Roche
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)
 
Rahul Raj Aggarwal
Research Funding - Gilead Sciences; Novartis; Sanofi; Zenith Epigenetics
 
Robert Benjamin Den
Consulting or Advisory Role - GenomeDx
Speakers' Bureau - Bayer
Research Funding - GenomeDx; Medivation/Astellas
Travel, Accommodations, Expenses - GenomeDx
 
Jonathan Lehrer
Employment - GenomeDx
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis
 
Jack Youngren
No Relationships to Disclose
 
Theodore C Goldstein
Employment - Guttman Initiatives
 
Joshi J. Alumkal
Consulting or Advisory Role - Astellas Pharma; Bayer
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Janssen (Inst); Millennium (Inst); Novartis (Inst); Zenith Epigenetics (Inst)
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Matthew Rettig
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - Johnson & Johnson
Research Funding - GlaxoSmithKline; Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Provisionapatent filed, no or-profit partner identified yet
Travel, Accommodations, Expenses - Johnson & Johnson
 
Christopher P. Evans
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation; Sanofi
Research Funding - Medivation
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Medivation; Sanofi
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Janssen; Janssen Biotech; Janssen Oncology; Janssen Research & Development; Johnson & Johnson; Pfizer; Roche
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio; Sotio (Inst); Theraclone Sciences (Inst)
 
Robert Evan Reiter
Stock and Other Ownership Interests - Inanovate
Consulting or Advisory Role - Astellas Pharma
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Jiaoti Huang
Honoraria - Optra SCAN
Consulting or Advisory Role - KingMed Diagnostics
Travel, Accommodations, Expenses - Optra SCAN
 
George V. Thomas
No Relationships to Disclose
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Daniel Eidelberg Spratt
No Relationships to Disclose
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)